566 related articles for article (PubMed ID: 10613720)
1. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
4. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
5. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
6. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
Margalit M; Elinav H; Goldin E; Ilan Y
Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
8. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
Björnsson E; Angulo P
Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
[TBL] [Abstract][Full Text] [Related]
11. Management of primary sclerosing cholangitis.
Björnsson E
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
[TBL] [Abstract][Full Text] [Related]
13. Early detection and treatment of cholangiocarcinoma.
Gores GJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
[TBL] [Abstract][Full Text] [Related]
14. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
[TBL] [Abstract][Full Text] [Related]
15. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
de Groen PC
Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
[No Abstract] [Full Text] [Related]
18. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary disease in inflammatory bowel disease.
Balan V; LaRusso NF
Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
